SCD1 Inhibition Strategy Shows Potent Synergy with Regorafenib and Metformin in Tumor Cell Killing
Our data demonstrates that UM cells are killed by treatment with aramchol plus regorafenib plus... read more
April 21, 2026
Tagged: regorafenib
Combining Regorafenib and TAS102 to Target Gastrointestinal Cancers and Overcome Cancer Stemness
In this research paper, researchers demonstrate a promising new treatment option for refractory metastatic gastrointestinal... read more
August 9, 2024